Therapeutic potential of human amylin analogues in diabetes mellitus

被引：4
|
作者：
Cooper, GJS
机构：
[1] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand
[2] Univ Auckland, Sch Med, Auckland, New Zealand
来源：
BIODRUGS | 1998年 / 10卷 / 01期
关键词：
D O I：
10.2165/00063030-199810010-00001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 9
页数：9
相关论文
共 50 条
  • [21] The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus
    Zhu, Liang
    Wang, Sheng
    Qu, JunSheng
    Hui, Zongguang
    Kan, Chengxia
    Hou, Ningning
    Sun, Xiaodong
    CELLULAR REPROGRAMMING, 2022, 24 (06) : 329 - 342
  • [22] Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2
    Prabhakar, Pranav Kumar
    Batiha, Gaber El-Saber
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (21) : 3167 - 3181
  • [23] Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview
    Palihaderu, P. A. D. S.
    Mendis, B. I. L. M.
    Premarathne, J. M. K. J. K.
    Dias, W. K. R. R.
    Yeap, Swee Keong
    Ho, Wan Yong
    Dissanayake, A. S.
    Rajapakse, I. H.
    Karunanayake, P.
    Senarath, U.
    Satharasinghe, D. A.
    EPIGENETICS INSIGHTS, 2022, 15
  • [24] The potential of esculin as a therapeutic modality in diabetes mellitus and its complications
    Naseem, Nida
    Ahmad, Md. Fahim
    Imam, Nazia
    Ahsan, Haseeb
    Siddiqui, Waseem A.
    HUMAN NUTRITION & METABOLISM, 2023, 33
  • [25] Therapeutic potential of melatonin as a chronobiotic and cytoprotective agent in diabetes mellitus
    Wajid, Fareha
    Poolacherla, Raju
    Mim, Fatiha Kabir
    Bangash, Amna
    Rutkofsky, Ian H.
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2020, 19 (02) : 1797 - 1825
  • [26] Therapeutic Potential of Fingolimod in Diabetes Mellitus and Its Chronic Complications
    Li, Jie
    Nan, Xinyu
    Ma, Yixuan
    Wang, Zhen
    Fang, Hui
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 507 - 516
  • [27] Therapeutic potential of melatonin as a chronobiotic and cytoprotective agent in diabetes mellitus
    Fareha Wajid
    Raju Poolacherla
    Fatiha Kabir Mim
    Amna Bangash
    Ian H. Rutkofsky
    Journal of Diabetes & Metabolic Disorders, 2020, 19 : 1797 - 1825
  • [28] The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus
    Fineman, M
    Weyer, C
    Maggs, DG
    Strobel, S
    Kolterman, OG
    HORMONE AND METABOLIC RESEARCH, 2002, 34 (09) : 504 - 508
  • [29] Insulin analogues and management of diabetes mellitus
    Balu Vaidyanathan
    P. S. N. Menon
    The Indian Journal of Pediatrics, 2000, 67 (6) : 435 - 441
  • [30] Therapeutic potential of multifunctional myricetin for treatment of type 2 diabetes mellitus
    Niisato, Naomi
    Marunaka, Yoshinori
    FRONTIERS IN NUTRITION, 2023, 10
12345